Cargando…
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
INTRODUCTION: One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). METHODS: We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three...
Autores principales: | Jutkowitz, Eric, Bynum, Julie P.W., Mitchell, Susan L., Cocoros, Noelle M., Shapira, Oren, Haynes, Kevin, Nair, Vinit P., McMahill‐Walraven, Cheryl N., Platt, Richard, McCarthy, Ellen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335904/ https://www.ncbi.nlm.nih.gov/pubmed/32647744 http://dx.doi.org/10.1002/dad2.12048 |
Ejemplares similares
-
Prevalence of Diagnosed Alzheimer’s Disease and Related Dementias in Medicare Advantage
por: Jutkowitz, Eric, et al.
Publicado: (2020) -
Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries
por: Desai, Urvi, et al.
Publicado: (2019) -
Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers
por: Ritter, Kerstin, et al.
Publicado: (2015) -
Multi‐time‐point data preparation robustly reveals MCI and dementia risk factors
por: Kaur, Daman, et al.
Publicado: (2020) -
Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample
por: Jung, Youngsin, et al.
Publicado: (2017)